...
首页> 外文期刊>BMJ: British medical journal >Changes to the regulation of drug prices in the UK Now the prices paid should reflect a medicine's clinical value
【24h】

Changes to the regulation of drug prices in the UK Now the prices paid should reflect a medicine's clinical value

机译:的变化在英国药品价格的监管现在的价格应该反映药物的临床价值

获取原文
获取原文并翻译 | 示例
           

摘要

On 11 December 2008 the Department of Health and the Association of the British Pharmaceutical Industry jointly published details of an agreement they had reached after nine months' negotiation for the pricing of brand name drugs sold to the NHS. The new terms, which came into effect on 1 January 2009 and will run for five years, are the latest in a continually evolving Pharmaceutical Price Regulation Scheme. Under the framework of this scheme, which was originally known as the Voluntary Price Regulation Scheme, government and industry have been negotiating "voluntary and non-contractual" terms for drug pricing since 1956, and the previous set of terms-which started in 2005-was due to run until 2010. However, in 2007 a market report from the Office of Fair Trading argued that the scheme was outdated, perverse, and not fit for purpose, and demanded that it be reformed. The government unilaterally withdrew from the 2005-10 scheme in February 2008 despite resistance from the drug industry. To what extent does the current scheme allay the Office of Fair Trading's criticisms?
机译:2008年12月11日卫生部英国医药协会产业联合出版的细节他们已经达成协议经过九个月的为品牌药物的定价谈判卖给了英国国民健康保险制度。影响2009年1月1日,并将运行5年,最新的在不断进化药品价格监管方案。最初的这个计划框架被称为自愿价格监管方案,政府和行业的谈判“自愿和非契约性”药物价格自1956年以来,和前面的组关键字,开始于2005年,是由于之前运行2010. 公平交易办公室认为该计划过时的、荒谬和不适用要求将其改革。单方面退出了2005 - 10年度计划2008年2月尽管抵制毒品行业。减轻公平交易办公室的批评?

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号